Annual CFF
-$11.17 M
-$10.89 M-3793.03%
December 31, 2023
Summary
- As of February 8, 2025, SNSE annual cash flow from financing activities is -$11.17 million, with the most recent change of -$10.89 million (-3793.03%) on December 31, 2023.
- During the last 3 years, SNSE annual CFF has fallen by -$46.63 million (-131.51%).
- SNSE annual CFF is now -106.82% below its all-time high of $163.94 million, reached on December 31, 2021.
Performance
SNSE Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$204.00 K
-$24.00 K-13.33%
September 30, 2024
Summary
- As of February 8, 2025, SNSE quarterly cash flow from financing activities is -$204.00 thousand, with the most recent change of -$24.00 thousand (-13.33%) on September 30, 2024.
- Over the past year, SNSE quarterly CFF has increased by +$227.00 thousand (+52.67%).
- SNSE quarterly CFF is now -100.12% below its all-time high of $164.08 million, reached on March 31, 2021.
Performance
SNSE Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$1.02 M
+$2.33 M+69.47%
September 30, 2024
Summary
- As of February 8, 2025, SNSE TTM cash flow from financing activities is -$1.02 million, with the most recent change of +$2.33 million (+69.47%) on September 30, 2024.
- Over the past year, SNSE TTM CFF has increased by +$10.15 million (+90.84%).
- SNSE TTM CFF is now -100.54% below its all-time high of $188.97 million, reached on March 31, 2021.
Performance
SNSE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SNSE Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3793.0% | +52.7% | +90.8% |
| 3 y3 years | -131.5% | -64.5% | -256.8% |
| 5 y5 years | -1589.7% | -64.5% | -256.8% |
SNSE Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -106.8% | at low | -271.4% | +97.4% | -100.6% | +90.8% |
| 5 y | 5-year | -106.8% | at low | -100.1% | +97.4% | -100.5% | +90.8% |
| alltime | all time | -106.8% | at low | -100.1% | +97.4% | -100.5% | +90.8% |
Sensei Biotherapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$204.00 K(+13.3%) | -$1.02 M(-69.5%) |
| Jun 2024 | - | -$180.00 K(-13.9%) | -$3.35 M(-69.8%) |
| Mar 2024 | - | -$209.00 K(-51.5%) | -$11.12 M(-0.5%) |
| Dec 2023 | -$11.17 M(+3793.0%) | -$431.00 K(-83.0%) | -$11.17 M(+2.8%) |
| Sep 2023 | - | -$2.53 M(-68.1%) | -$10.87 M(+27.9%) |
| Jun 2023 | - | -$7.95 M(+2932.8%) | -$8.49 M(+1171.7%) |
| Mar 2023 | - | -$262.00 K(+111.3%) | -$668.00 K(+132.8%) |
| Dec 2022 | -$287.00 K | -$124.00 K(-23.9%) | -$287.00 K(+2.1%) |
| Sep 2022 | - | -$163.00 K(+37.0%) | -$281.00 K(+124.8%) |
| Jun 2022 | - | -$119.00 K(-200.0%) | -$125.00 K(+635.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $119.00 K(-200.8%) | -$17.00 K(-100.0%) |
| Dec 2021 | $163.94 M(+362.4%) | -$118.00 K(+1585.7%) | $163.94 M(-8.9%) |
| Sep 2021 | - | -$7000.00(-36.4%) | $179.92 M(-4.5%) |
| Jun 2021 | - | -$11.00 K(-100.0%) | $188.41 M(-0.3%) |
| Mar 2021 | - | $164.08 M(+934.6%) | $188.97 M(+433.0%) |
| Dec 2020 | $35.45 M(+331.2%) | $15.86 M(+87.0%) | $35.45 M(+80.9%) |
| Sep 2020 | - | $8.48 M(+1425.4%) | $19.59 M(+76.3%) |
| Jun 2020 | - | $556.00 K(-94.7%) | $11.11 M(+5.3%) |
| Mar 2020 | - | $10.56 M | $10.56 M |
| Dec 2019 | $8.22 M(+996.3%) | - | - |
| Dec 2018 | $750.00 K | - | - |
FAQ
- What is Sensei Biotherapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics annual CFF year-on-year change?
- What is Sensei Biotherapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics quarterly CFF year-on-year change?
- What is Sensei Biotherapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Sensei Biotherapeutics?
- What is Sensei Biotherapeutics TTM CFF year-on-year change?
What is Sensei Biotherapeutics annual cash flow from financing activities?
The current annual CFF of SNSE is -$11.17 M
What is the all time high annual CFF for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high annual cash flow from financing activities is $163.94 M
What is Sensei Biotherapeutics annual CFF year-on-year change?
Over the past year, SNSE annual cash flow from financing activities has changed by -$10.89 M (-3793.03%)
What is Sensei Biotherapeutics quarterly cash flow from financing activities?
The current quarterly CFF of SNSE is -$204.00 K
What is the all time high quarterly CFF for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high quarterly cash flow from financing activities is $164.08 M
What is Sensei Biotherapeutics quarterly CFF year-on-year change?
Over the past year, SNSE quarterly cash flow from financing activities has changed by +$227.00 K (+52.67%)
What is Sensei Biotherapeutics TTM cash flow from financing activities?
The current TTM CFF of SNSE is -$1.02 M
What is the all time high TTM CFF for Sensei Biotherapeutics?
Sensei Biotherapeutics all-time high TTM cash flow from financing activities is $188.97 M
What is Sensei Biotherapeutics TTM CFF year-on-year change?
Over the past year, SNSE TTM cash flow from financing activities has changed by +$10.15 M (+90.84%)